Cargando…
Short-term safety and efficacy of intravitreal 0.7-mg dexamethasone implants for pseudophakic cystoid macular edema
AIMS: To determine the feasibility, safety, and clinical efficacy of intravitreal 0.7-mg dexamethasone implants (Ozurdex) in patients with refractory cystoid macular edema after uncomplicated cataract surgery. METHODS AND MATERIALS: In this study, 11 eyes of 11 patients affected by pseudophakic cyst...
Autor principal: | Al Zamil, Waseem M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398816/ https://www.ncbi.nlm.nih.gov/pubmed/25892932 http://dx.doi.org/10.1016/j.sjopt.2014.10.005 |
Ejemplares similares
-
Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants
por: Brynskov, Troels, et al.
Publicado: (2013) -
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019) -
Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
por: Meyer, Linda M., et al.
Publicado: (2011) -
Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
por: Kakkassery, Vinodh, et al.
Publicado: (2017) -
Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
por: Dang, Yalong, et al.
Publicado: (2014)